Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-45.03	53.79	97.86
Graham Fair Price	-28.85	1.14	1.61
PEG	42.73	0.57	-0.40
Price/Book	-2.76	0.61	0.63
Price/Cash Flow	-72.61	6.75	24.63
Prices/Earnings	90.94	-86.22	45.15
Price/Sales	-7.85	1.44	1.57
Price/FCF	-72.61	6.75	24.63
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	-10.60	0.10	0.12
Operating Margin	40.92	0.04	0.03
ROA	-47.48	< 0.005	< 0.005
ROE	< 0.005	< 0.005	-49.07
ROIC	0.01	< 0.005	-92.33
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	-0.06	0.01	413.50
Dividends QOQ	-0.27	0.11	-60.59
EBIT QOQ	5.04	0.48	-90.42
EPS QOQ	1.13	-1.51	33.78
FCF QOQ	-0.35	2.54	632.32
Revenue QOQ	-0.02	0.05	179.76
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	76.46	60.67	-20.64
Days Sales Outstanding (DSO)	72.50	134.30	85.25
Inventory Turnover	1.18	1.48	26.01
Debt/Capitalization	0.74	0.73	-1.66
Quick Ratio	0.37	0.48	31.04
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	5.73	7.55	31.78
Cash	4.56	3.92	-13.94
Capex	-0.02	< 0.005	-78.59
Free Cash Flow	0.15	0.52	254.01
Revenue	2.30	2.42	5.21
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	0.58	0.57	-2.25
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	76.00	41.71	-45.12
Naive Interpretation	Member

06 - Financial Health · Bad

Rating